Tirzepatide as a research peptide is evaluated by labs on sequence identity, verified purity and analytical documentation, not on any therapeutic claims.
This guide explains what a laboratory should verify when sourcing the tirzepatide research peptide, strictly for research use.
Sequence and Identity
Identity is confirmed by matching the peptide sequence and mass via LC-MS, which distinguishes the correct compound from related or degraded forms.
Purity Verification
A HPLC or LC-MS certificate at 98% or above is the standard evidence a lab should request before any study.
Storage and Reconstitution
The lyophilised peptide requires cold, dry storage and careful reconstitution under lab conditions to remain stable.
Research-Only Boundary
This material is for laboratory and research purposes only and is not intended for human use or any therapeutic application.
Frequently Asked Questions
How is tirzepatide verified? By LC-MS identity matching and HPLC purity analysis, documented in a certificate.
What purity is standard? Commonly 98% or higher, per the certificate of analysis.
How should it be stored? Lyophilised, cold and dry, before controlled reconstitution.
{DISCLAIMER}
{OUTBOUND}
Questions about the tirzepatide research peptide? Reach us on {WA}.
{INTERNAL}
